Moreover, levels of the circulating ovarian cancer marker, CA125/mucin 16, declined from ∼700 units/ml in control vehicle-treated mice to undetectable in all of the BHPI plus paclitaxel treated mice. The gene discussed is MUC16; the disease is ovarian carcinoma.